Literature DB >> 2280582

Complications of plasma exchange in patients with neurological diseases.

T Henze1, H W Prange, J Talartschik, K W Rumpf.   

Abstract

Plasma exchange has proven to be effective in diseases of established or presumed autoimmune etiology as well as in hyperviscosity syndromes and some rare metabolic disorders. Its application is thought to be relatively safe; nevertheless, severe complications may occur. We therefore analyzed the complications of 291 exchanges in 39 patients with neurological diseases. Minor complications developed in 4.8% and major complications in 2.7% of procedures, including one death. Severe infections and technical problems have been the most serious side effects, sometimes followed by organ failure or even death.

Entities:  

Mesh:

Year:  1990        PMID: 2280582      PMCID: PMC7096018          DOI: 10.1007/bf01815277

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  14 in total

1.  [Central nervous system infection caused by Aspergillus fumigatus. A complication of immunosuppressive therapy in myasthenia gravis].

Authors:  R Nau; T Behrends; T Henze; H W Prange
Journal:  Nervenarzt       Date:  1989-03       Impact factor: 1.214

2.  [Autonomic nervous system functional disorders in acute Guillain-Barré-Strohl polyradiculitis].

Authors:  T Henze; H W Prange; G Ritter
Journal:  Dtsch Med Wochenschr       Date:  1986-07-04       Impact factor: 0.628

3.  Efficiency of plasma exchange in Guillain-Barré syndrome: role of replacement fluids. French Cooperative Group on Plasma Exchange in Guillain-Barré syndrome.

Authors: 
Journal:  Ann Neurol       Date:  1987-12       Impact factor: 10.422

4.  Complications of plasma exchange.

Authors:  D M Sutton; R C Nair; G Rock
Journal:  Transfusion       Date:  1989-02       Impact factor: 3.157

5.  Transmission of HIV and AIDS by plasmapheresis for Guillain-Barré syndrome.

Authors:  C A Boucher; J de Gans; R van Oers; S Danner; J Goudsmit
Journal:  Clin Neurol Neurosurg       Date:  1988       Impact factor: 1.876

Review 6.  Therapeutic plasma exchange.

Authors:  K H Shumak; G A Rock
Journal:  N Engl J Med       Date:  1984-03-22       Impact factor: 91.245

7.  Plasmapheresis and acute Guillain-Barré syndrome. The Guillain-Barré syndrome Study Group.

Authors: 
Journal:  Neurology       Date:  1985-08       Impact factor: 9.910

8.  Complications during therapeutic plasma exchange.

Authors:  F Keller; G Schultze; G Offermann; M Molzahn
Journal:  Acute Care       Date:  1985

9.  Infectious complications with plasmapheresis in rapidly progressive glomerulonephritis.

Authors:  E J Wing; F J Bruns; D S Fraley; D P Segel; S Adler
Journal:  JAMA       Date:  1980-11-28       Impact factor: 56.272

10.  Potential danger of thrombosis after plasma exchange in the treatment of patients with immune disease.

Authors:  Y Sultan; A Bussel; P Maisonneuve; M Poupeney; X Sitty; P Gajdos
Journal:  Transfusion       Date:  1979 Sep-Oct       Impact factor: 3.157

View more
  6 in total

Review 1.  Juvenile myasthenia: diagnosis and treatment.

Authors:  B Anlar
Journal:  Paediatr Drugs       Date:  2000 May-Jun       Impact factor: 3.022

2.  Therapeutic Plasma Exchange in Patients with Neurologic Disorders: Review of 63 Cases.

Authors:  Anil Tombak; Mehmet Ali Uçar; Aydan Akdeniz; Arda Yilmaz; Hakan Kaleagası; Mehmet Ali Sungur; Eyup Naci Tiftik
Journal:  Indian J Hematol Blood Transfus       Date:  2016-02-22       Impact factor: 0.900

3.  Guillain-Barré syndrome in pregnancy--two case reports and a discussion on management.

Authors:  A Bolik; J Wissel; A Rolfs
Journal:  Arch Gynecol Obstet       Date:  1995       Impact factor: 2.344

4.  Management of acute exacerbations in multiple sclerosis.

Authors:  Daniel Ontaneda; Alex D Rae-Grant
Journal:  Ann Indian Acad Neurol       Date:  2009-10       Impact factor: 1.383

5.  Successful treatment of propafenone, digoxin and warfarin overdosage with plasma exchange therapy and rifampicin.

Authors:  Sule Unal; Benan Bayrakci; Umit Yasar; Tevfik Karagoz
Journal:  Clin Drug Investig       Date:  2007       Impact factor: 2.859

6.  Updates on clinically isolated syndrome and diagnostic criteria for multiple sclerosis.

Authors:  Jacqueline F Marcus; Emmanuelle L Waubant
Journal:  Neurohospitalist       Date:  2013-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.